Hepatitis B at a Crossroads: Breaking Barriers in Diagnosis and Treatment
16:08
YouTubeMedscape
Hepatitis B at a Crossroads: Breaking Barriers in Diagnosis and Treatment
Join us for a social media event on hepatitis B diagnosis and treatment designed to encourage the exchange of ideas between leaders in the field and attendees. John W. Ward, MD Director, Coalition for Global Hepatitis Elimination Atlanta, Georgia Stacey B. Trooskin, MD, PhD Chief Medical Officer, Mazzoni Center Philadelphia, Pennsylvania For ...
614 views4 months ago
Related Products
Medscape Mug
Medscape Pen
Medscape Scrubs
#Medscape News
Breaking News in IBD: Advancing Confidence in Optimizing Subcutaneous Anti-TNF Treatment Across the Care Continuum | Medscape
Breaking News in IBD: Advancing Confidence in Optimizing Subcutaneous Anti-TNF Treatment Across the Care Continuum | Medscape
Facebook1 month ago
The Truth About Vaping
The Truth About Vaping
medscape.comDec 11, 2023
Top videos
Sep 12 2025 This Week in Cardiology
31:05
Sep 12 2025 This Week in Cardiology
YouTubeMedscape
488 views3 months ago
Medscape AI: Insight grounded in experience.
0:59
Medscape AI: Insight grounded in experience.
YouTubeMedscape
476 views3 weeks ago
Quick Take: Asthma–COPD Overlap Syndrome
1:29
Quick Take: Asthma–COPD Overlap Syndrome
YouTubeMedscape
474 views2 weeks ago
Medscape CME Courses
Managing FCS is notoriously difficult. With standard lipid-lowering therapies often failing, strict diet has historically been the only tool. In this CME program, Dr. Shapiro reviews the pathophysiology and strategies to reduce pancreatitis risk. Watch the full video ➡️ https://www.facebook.com/watch/live/?ref=watch_permalink&v=1171021224648318 #CME | Medscape
0:32
Managing FCS is notoriously difficult. With standard lipid-lowering therapies often failing, strict diet has historically been the only tool. In this CME program, Dr. Shapiro reviews the pathophysiology and strategies to reduce pancreatitis risk. Watch the full video ➡️ https://www.facebook.com/watch/live/?ref=watch_permalink&v=1171021224648318 #CME | Medscape
FacebookMedscape
71 views2 weeks ago
Oral TKI or IV ADC for HER2 NSCLC? The first oral medication for this disease, Zongertinib, is now approved, joining established IV therapies like Trastuzumab deruxtecan. Our experts discuss how to choose ▶️ https://www.facebook.com/events/566988496426095 #Oncology #CME | Medscape
Oral TKI or IV ADC for HER2 NSCLC? The first oral medication for this disease, Zongertinib, is now approved, joining established IV therapies like Trastuzumab deruxtecan. Our experts discuss how to choose ▶️ https://www.facebook.com/events/566988496426095 #Oncology #CME | Medscape
FacebookMedscape
382 views2 months ago
Implicit Bias: It's in All of Us
Implicit Bias: It's in All of Us
medscape.com
Feb 7, 2018